Nicholas Albrecht Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9515 Birch Run Rd, Birch Run, MI 48415 Phone: 989-624-1610 |
Ms. Sarah Elizabeth Block, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 9515 Birch Run Rd, Birch Run, MI 48415 Phone: 989-624-1610 |
Miss Emily Shoup, PHARM.D, B.S. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9515 Birch Run Rd, Birch Run, MI 48415 Phone: 989-624-1665 Fax: 989-624-1665 |
Kyle Rich Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 9515 Birch Run Rd, Birch Run, MI 48415 Phone: 989-624-1610 |
News Archive
According to a new market research report by Allied Market Research titled, "GlobalRegenerative MedicineMarket (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020).
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
New research from a Swedish and Danish team of researchers led from Karolinska Institutet lend additional support to a link between treatment with fluoroquinolone antibiotics and an increased risk of acute aortic disease. The study is published in the esteemed journal The BMJ.
Exposure to long-term obesity has become more common with increases in obesity at younger ages. Researchers examined the relationship between BMI at age 25, obesity later in life, and biological indicators of health.
Research-clinicians at Children's National Health System have created a novel preclinical model that mimics the persistent interneuron loss seen in preterm human infants, identifying interneuron subtypes that could become future therapeutic targets to prevent or lessen neurodevelopmental risks, the team reports Jan. 31, 2019, in eNeuro.
› Verified 9 days ago